Position- and orientation-specific enhancement of topoisomerase I cleavage complexes by triplex DNA structures

被引:12
作者
Antony, S
Arimondo, PB
Sun, JS
Pommier, Y
机构
[1] NCI, Mol Pharmacol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA
[2] CNRS MNHN, UMR 5153, USM Museum Natl Hist Nat 0503, INSERM,U565, F-75231 Paris 05, France
关键词
D O I
10.1093/nar/gkh847
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Topoisomerase I (Top1) activities are sensitive to various endogenous base modifications, and anticancer drugs including the natural alkaloid camptothecin. Here, we show that triple helix-forming oligonucleotides (TFOs) can enhance Top1-mediated DNA cleavage by affecting either or both the nicking and the closing activities of Top1 depending on the position and the orientation of the triplex DNA structure relative to the Top1 site. TFO binding 1 bp downstream from the Top1 site enhances cleavage by inhibiting religation and to a lesser extent DNA nicking. In contrast, TFO binding 4 bp downstream from the Top1 site enhances DNA nicking especially when the 3' end of the TFO is proximal to the Top1 site. However, when the orientation of the triplex is inverted, with its 5' terminus 4 bp downstream from the Top1 site, religation is also inhibited. These position- and orientation-dependent effects of triplex structures on the Top1-mediated DNA cleavage and religation are discussed in the context of molecular modeling and effects of TFO on DNA twist and mobility at the duplex/triplex junction.
引用
收藏
页码:5163 / 5173
页数:11
相关论文
共 53 条
[21]   CAMPTOTHECIN INHIBITS BOTH THE CLEAVAGE AND RELIGATION REACTIONS OF EUKARYOTIC DNA TOPOISOMERASE-I [J].
KJELDSEN, E ;
SVEJSTRUP, JQ ;
GROMOVA, II ;
ALSNER, J ;
WESTERGAARD, O .
JOURNAL OF MOLECULAR BIOLOGY, 1992, 228 (04) :1025-1030
[22]   EUKARYOTIC TOPOISOMERASE-I-DNA INTERACTION IS STABILIZED BY HELIX CURVATURE [J].
KROGH, S ;
MORTENSEN, UH ;
WESTERGAARD, O ;
BONVEN, BJ .
NUCLEIC ACIDS RESEARCH, 1991, 19 (06) :1235-1241
[23]   Human topoisomerase I inhibition: Docking camptothecin and derivatives into a structure-based active site model [J].
Laco, GS ;
Collins, JR ;
Luke, BT ;
Kroth, H ;
Sayer, JM ;
Jerina, DM ;
Pommier, Y .
BIOCHEMISTRY, 2002, 41 (05) :1428-1435
[24]   THE DEFINITION OF GENERALIZED HELICOIDAL PARAMETERS AND OF AXIS CURVATURE FOR IRREGULAR NUCLEIC-ACIDS [J].
LAVERY, R ;
SKLENAR, H .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 1988, 6 (01) :63-91
[25]   THE FLEXIBILITY OF THE NUCLEIC-ACIDS .2. THE CALCULATION OF INTERNAL ENERGY AND APPLICATIONS TO MONONUCLEOTIDE REPEAT DNA [J].
LAVERY, R ;
SKLENAR, H ;
ZAKRZEWSKA, K ;
PULLMAN, B .
JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 1986, 3 (05) :989-1014
[26]   8-oxoguanine rearranges the active site of human topoisomerase I [J].
Lesher, DTT ;
Pommier, Y ;
Stewart, L ;
Redinbo, MR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (19) :12102-12107
[27]   Resolution of undistorted symmetric immobile DNA junctions by vaccinia topoisomerase I [J].
Liao, SP ;
Mao, CD ;
Birktoft, JJ ;
Shuman, S ;
Seeman, NC .
BIOCHEMISTRY, 2004, 43 (06) :1520-1531
[28]   Interaction of human nuclear topoisomerase I with guanosine quartet-forming and guanosine-rich single-stranded DNA and RNA oligonucleotides [J].
Marchand, C ;
Pourquier, P ;
Laco, GS ;
Jing, NJ ;
Pommier, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (11) :8906-8911
[29]  
Mills Martin, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P627, DOI 10.2174/1568011023353877
[30]  
Nitiss JL, 1996, MOL PHARMACOL, V50, P1095